MorningRX: August 11, 2023
Drug Topics
AUGUST 11, 2023
HHS awards money to fight the nursing shortage, the FDA approves Johnson & Johnson's talquetamab-tgvs (TALVEY), and the CDC says suicides reached an all-time high in 2022.
Drug Topics
AUGUST 11, 2023
HHS awards money to fight the nursing shortage, the FDA approves Johnson & Johnson's talquetamab-tgvs (TALVEY), and the CDC says suicides reached an all-time high in 2022.
Pharmacy Times
AUGUST 11, 2023
Jennifer Chesak, author of The Psilocybin Handbook for Women, discusses how estrogen can affect binding at the serotonin receptor sites, causing psilocybin to impact women’s bodies differently.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
AUGUST 11, 2023
A substantial collection of evidence indicates that the fallopian tube serves as the primary site of origin for a large portion of high-grade serous ovarian cancers.
Pharmacy Times
AUGUST 11, 2023
Gretchen Garofoli, PharmD, an associate professor at the West Virginia School of Pharmacy, discusses the current recommendations for COVID-19, respiratory syncytial virus (RSV), and influenza vaccines and vaccine hesitancy.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Drug Topics
AUGUST 11, 2023
According to the National Community Pharmacists Association, 97% of independent pharmacy owners reported shortages of Adderall in early 2023.
Pharmacy Times
AUGUST 11, 2023
Unexpectedly, the highest increases in delirium compared to projections were in the 66 to 74 years of age group, which could have important personal and societal repercussions, such as earlier development of dementia.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Pharmacy Times
AUGUST 11, 2023
New standards from the National Council for Prescription Drug Programs could drive changes that improve patient safety by optimizing drug therapy to reduce the risk of harm and improve health and well-being before a medication is dispensed.
Fierce Pharma
AUGUST 11, 2023
It’s been a rough summer for pharmaceutical companies trying to resolve lawsuits by declaring bankruptcy. | The Supreme Court has halted Purdue Pharma’s $6-billion bankruptcy settlement, which granted the company’s former owners—the Sackler family—immunity from civil suits related to the opioid crisis.
Pharmacy Times
AUGUST 11, 2023
Despite the low uptake of healthy lifestyle behaviors to achieve 5% weight loss or greater, the probability of weight loss increased among individuals with higher initial BMI.
Fierce Healthcare
AUGUST 11, 2023
Microsoft rolled out a new electronic health records cloud database solution, leveraging Azure Large Instances, that enables health systems to scale capacity for high-volume workloads. | Microsoft rolled out a new electronic health records cloud database solution, leveraging Azure Large Instances, that enables health systems to scale capacity for high-volume workloads.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Pharmacy Times
AUGUST 11, 2023
In the COLUMBUS study, the FDA requested that the investigators evaluate the contribution of binimetinib while maintaining the same dosage of encorafenib at 300 mg to confirm the benefits of the combination.
STAT
AUGUST 11, 2023
HELSINKI — It was the quiet that stood out to Tarja Sironen at the fur farm. A specialist in emerging infectious diseases, Sironen has conducted research at fur farms for years. She helped develop a Covid vaccine that was deployed to the country’s mink population during the pandemic. She knows the industry well.
Pharmacy Times
AUGUST 11, 2023
Advancements in the development of amyloid-targeting monoclonal antibodies show promise for treating Alzheimer disease, but there have been concerns around cost, adverse reactions, and inequity of care for marginalized patients.
PharmExec
AUGUST 11, 2023
How pharma medical affairs and commercial teams are synchronizing their capabilities to boost omnichannel marketing strategies and better understand customer engagement needs.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Pharmacy Times
AUGUST 11, 2023
Although SB5 is an effective treatment for plaque psoriasis, it is recommended that patients consider the potential risks and adverse effects.
Fierce Pharma
AUGUST 11, 2023
Amylyx Pharmaceuticals’ amyotrophic lateral sclerosis (ALS) drug Relyvrio continues to wow Wall Street. | Amylyx’s amyotrophic lateral sclerosis drug Relyvrio ​​​​​​​continues to wow Wall Street. The drug brought in $98.2 million revenue in the second quarter, handily beating analysts’ consensus estimates of below $92 million.
Pharmacy Times
AUGUST 11, 2023
Pharmacy technicians are stepping up to assume expanded responsibilities that contribute to pharmacy management and patient safety.
The Checkup by Singlecare
AUGUST 11, 2023
Pain management is essential to the treatment plan when someone is suffering. However, figuring out the right course of action for a particular condition can be difficult. There are many ways to worsen and prolong pain if not managed properly. People with diverticulitis often experience abdominal pain during or after eating a meal. Eating is a part of everyday life, so coping with a condition that is worsened by eating can be challenging.
Pharmacy Times
AUGUST 11, 2023
The study implemented a novel workflow for ambulatory care pharmacists to execute pharmacist-administered depression screenings.
STAT
AUGUST 11, 2023
One person has died and at least four have been sickened by tuberculosis in infected bone materials, an outbreak that has cast a spotlight on the shortcomings of testing for such tissue products. It’s the second tuberculosis outbreak linked to the biomaterial device company, Aziyo Biologics. In 2021, Aziyo’s product killed eight people after orthopedic and dental surgeons unwittingly implanted infected bone grafts into patients.
Fierce Pharma
AUGUST 11, 2023
Less than a month after the family of Henrietta Lacks reached a settlement with Thermo Fisher over its use of Lacks’ cells, another drugmaker stands accused of profiting from a racist medical syste | Less than a month after the family of Henrietta Lacks reached a settlement with Thermo Fisher over its use of Lacks’ cells, another drugmaker stands accused of profiting from a racist medical system.
STAT
AUGUST 11, 2023
Nearly every hospital pharmacy across the U.S. is experiencing shortages of prescription drugs. And the problem has become so bad – especially for chemotherapies — that one-third of hospital pharmacists reported their institutions are rationing, delaying, or canceling treatments or procedures, according to a new survey. Specifically, 99% of hospitals pharmacists reported shortages, which is causing 85% to ration treatments and 84% to rely on different dosages.
Fierce Healthcare
AUGUST 11, 2023
Access to care for Medicaid fee-for-service beneficiaries with substance use disorder has improved from 2014 until 2021, but much more can be done to improve it further, researchers say. | There have been substantial improvements in coverage for substance use disorder and opioid use disorder since 2014, according to a study in JAMA Network. Nonetheless, there’s room for yet more improvement.
PharmExec
AUGUST 11, 2023
From public defender to spearheading the adoption of innovative drugs, Wendy Short Bartie, senior VP and general manager for the hematology and cell therapy division at Bristol Myers Squibb, has remained a steadfast patient advocate—working to fulfill unmet medical needs and bring treatments to as many people as possible.
The Checkup by Singlecare
AUGUST 11, 2023
Propranolol is an old drug that just won’t go away, for good reason. It touts a 50-year history of utility, originally as a treatment for heart disease and later as a preventive treatment for migraine, a use that has landed it on the World Health Organization’s list of essential medications. A role for propranolol that you may find more interesting is in the treatment of anxiety.
Fierce Pharma
AUGUST 11, 2023
Bristol Myers Squibb has laid off more than 100 employees amid a reconfiguration of expenses that follows disappointing earnings results. | Bristol Myers Squibb has laid off more than 100 employees amid a reconfiguration of expenses that follows disappointing earnings results.
STAT
AUGUST 11, 2023
So many promising medical innovations never reach their full potential as therapies or cures, languishing instead in a metaphoric place many of us in biotech know as “the Valley of Death.” This valley represents the gap between when a scientist makes a discovery and when that work has reached the point when a pharmaceutical company will license it, or a venture capital firm will invest in it, to get it to the point to help the patients who need it.
Fierce Healthcare
AUGUST 11, 2023
The Department of Justice (DOJ) is requesting more information from Amedisys regarding its proposed $3.3 billion deal to be acquired by UnitedHealth Group, which pushes back the timing of the deal. | The Department of Justice is requesting more information from Amedisys regarding its proposition $3.3 billion acquisition by UnitedHealth Group, which pushes back the timing of the deal.
Hospital Pharmacy Europe
AUGUST 11, 2023
The risk of overdose from prescribed medicines used to overcome drug addiction is higher when patients are taking other medication, such as opioid agonists, according to a new study from the University of Manchester. In some cases, patients were more than twice as likely to be hospitalised with an overdose if they were taking opioid agonists in combination with prescribed drugs to treat mental health conditions or relieve pain, such as benzodiazepines, gabapentinoids, antipsychotics or Z-drugs
Fierce Pharma
AUGUST 11, 2023
Since Pfizer’s smoking cessation drug Chantix was recalled in 2021, Endo's subsidiary Par Pharmaceuticals has been the only one to market the product. | Endo alleges that Zydus Pharmaceuticals infringed upon its Chantix patent, asserting that there is no alternative method for producing the drug without the impurities that led to the removal of Pfizer's original product from the market.
STAT
AUGUST 11, 2023
WASHINGTON — A White House task force created to work on drug shortage reforms has yet to contact the lawmakers who are writing legislation to stem shortages — and it’s not clear when the task force will recommend policies. The White House formed a task force at the beginning of 2023 to deal with the issue of persistent drug shortages.
The Checkup by Singlecare
AUGUST 11, 2023
After an evening that included sipping some alcoholic drinks, you may want to pop a few ibuprofen to ward off a hangover the next day. Or maybe you took a couple of ibuprofen earlier in the day, and now you’re craving a beer. But the question is, should you do that? How long after taking ibuprofen can you drink alcohol? Experts suggest combining alcohol and ibuprofen can raise the risk of serious side effects, including kidney damage and liver problems and gastrointestinal bleeding.
Drug Store News
AUGUST 11, 2023
Plerixafor injection is a hematopoietic stem cell mobilizer used in combination with granulocyte-colony stimulating factor in patients with non-Hodgkin's lymphoma or multiple myeloma.
Fierce Healthcare
AUGUST 11, 2023
While major payers issued warnings to investors ahead of second-quarter earnings about rising utilization rates, patients returning to deferred services did not prevent these companies from turning | While major payers issued warnings to investors ahead of second-quarter earnings about rising utilization rates, patients returning to deferred services did not prevent these companies from turning a profit.
Let's personalize your content